Navigation Links
Advanced Life Sciences Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/19/2008

2006.

2007 Achievements

-- Completed and reported positive results from Trial CL-07, a thorough

QT study for cethromycin which showed that cethromycin had no effect

on QT changes, supporting its favorable cardiac safety profile;

-- Completed private placement financing with existing and new

shareholders which added net proceeds of $18 million in cash to the

balance sheet;

-- Progressed negotiations with multiple prospective partners regarding

the commercial development of cethromycin as a treatment for CAP;

-- Completed clinical development and released positive efficacy and

safety data from two pivotal Phase III clinical trials that enrolled

over 1,100 patients from over 200 clinical sites worldwide for the use

of cethromycin to treat CAP;

-- Engaged an outside contract research organization to complete medical

writing activities and conversion of the NDA database into electronic

filing format;

-- Completed API and drug product manufacturing and initiated stability

testing to support the CMC requirements for the cethromycin NDA

submission;

-- Completed microbiology surveillance studies necessary for the

cethromycin NDA submission;

-- Completed efficacy study in which cethromycin was shown to be

100% protective in preventing inhalation anthrax in non-human

primates;

-- Granted Orphan Drug Designation by the FDA for the use of cethromycin

in the prophylactic treatment of patients exposed to inhalation

anthrax;

-- Presented 11 posters on cethromycin at The American Society for

Microbiology's 47th Annual Interscience Conference on Antimicrobial

Agents and Chemotherapy (ICAAC) in Chicago and the 45th Annual Meeting

of the Infectious Disease Society of America (IDSA) in San Diego;

-- Forme
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
3. Advanced Cell Technology Announces Proposed Financing
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
6. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
7. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
8. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
9. Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System
10. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
11. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Sept. 18, 2014 About POCT ... performed outside a clinical laboratory. It helps in ... appropriate treatments and medication. POCT is gaining popularity ... lifestyle diseases such as diabetes, heart disease, and ... devices are standardized to minimize errors during the ...
(Date:9/18/2014)... 18, 2014 A novel robotic system ... scanner is currently being tested as part of a ... in Boston with the aim of determining if the ... prostate cancer biopsies faster, more accurate, less costly, and ... has the potential to deliver prostate cancer therapies with ...
(Date:9/18/2014)... DUBLIN, Ireland , September 18, ... ,Research and Markets ( http://www.researchandmarkets.com/research/czvg3s/biocompatible ) ... "Biocompatible Materials - Global Strategic ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,This report ... Materials in US$ Million by the ...
(Date:9/18/2014)... 2014 On Tuesday, Secretary of Energy ... Risch for National Lab Day on the Hill. The ... national laboratory system. Durbin and Risch also formally launched ... awareness of the reach of the national labs as ... address some of our nation's most pressing challenges. , ...
Breaking Biology Technology:POCT Market in China 2014-2018 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 2Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 3Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 4Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 5Worcester Polytechnic Institute Participates in Clinical Trial for MRI-Compatible Robot Designed to Improve Accuracy of Prostate Cancer Biopsies 6Biocompatible Materials - Global Strategic Business Report 2014 2Biocompatible Materials - Global Strategic Business Report 2014 3Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 2Lab Day Highlight Labs' Contribution to U.S. Competitiveness and Innovation 3
... ERES ), a leading provider of centralized,electrocardiographic ... will release its 2008 first quarter results for ... 5,2008 after the market closes.,After the release, the ... PM ET,later that day., For the conference ...
... KENILWORTH, N.J., April 23 Schering-Plough,Corporation (NYSE: ... animal,health products from 12 product franchises in Europe. ... by the European Commission as part,of its October ... health business from Akzo Nobel N.V., In ...
... Summary: At Genmab A/S,Annual General Meeting held today ... approved, discharge was given to the Board of Directors ... Two members of the,Board of Directors were re-elected and ... from the Board of,Directors to change the Articles of ...
Cached Biology Technology:eResearchTechnology, Inc. to Announce 2008 First Quarter Results on May 5, 2008 2Schering-Plough Announces Planned Divestiture of Select Animal Health Products in Europe 2Passing of Genmab A/S' Annual General Meeting 2Passing of Genmab A/S' Annual General Meeting 3Passing of Genmab A/S' Annual General Meeting 4
(Date:9/19/2014)... new resource unveiled today by researchers from several ... Dublin provides both experienced and aspiring researchers with ... and operate robots made from soft, flexible materials. ... laser cutters, and other advances in manufacturing technology, ... field. Using principles drawn from conventional rigid robot ...
(Date:9/19/2014)... A University of Oklahoma biology professor will study ... control leg movements with a National Science Foundation ... four-year project. , Ari Berkowitz, professor in the ... Sciences, will focus on the differences between the ... understand what neurotransmitters they use and what connections ...
(Date:9/19/2014)... a species which over thousands of years has adapted to ... substance that makes the cold dangerous for you. , This ... , and the cold provoking substance, called nonylphenol, comes from ... is suspected of being a endocrine disruptor, but when entering ... worm,s ability to protect the cells in its body from ...
Breaking Biology News(10 mins):Soft robotics 'toolkit' features everything a robot-maker needs 2Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3
... An anticipated increased incidence of climate-related extreme rainfall events ... risk for the 40 million people who depend on the ... In a report published today (Oct. 7, 2008) in ... of Wisconsin researchers reports that a trend toward extreme weather ...
... fish are created equal. A report scheduled to ... the journal Proceedings of the National Academy of ... herbivorous fishes may be critical to restoring coral reefs, ... from a long-term study that found significant recovery in ...
... of the first comparisons of its kind, researchers have demonstrated ... hold onto about 80 percent more carbon than can wetlands ... wetlands in Costa Rica and in Ohio and analyzed the ... on their analysis, they estimated that the tropical wetland accumulated ...
Cached Biology News:Waterborne disease risk upped in Great Lakes 2Waterborne disease risk upped in Great Lakes 3Diversity of plant-eating fishes may be key to recovery of coral reefs 2Diversity of plant-eating fishes may be key to recovery of coral reefs 3Diversity of plant-eating fishes may be key to recovery of coral reefs 4Study: Tropical wetlands hold more carbon than temperate marshes 2Study: Tropical wetlands hold more carbon than temperate marshes 3
Cell Culture Flask, 175 cm, tissue-culture treated polystyrene, barcoded...
... an aqueous solution that contains a purified ... a PBS buffer (phosphate buffered saline), pH ... a combination of 0.02% methylisothiazolone and 0.02% ... Stabilizer provides optimum performance for both microsphere ...
... clone K28/86.2, PDZ Domain GenBank ... : GST fusion to residues 77-299 ... Tris pH 7.4, 0.075M NaCl containing ... evaluated by immunoblot on rat brain ...
... The ProteoPrep 20 Plasma Immunodepletion Kit ... proteins from human plasma or serum in ... enables deeper penetration into the plasma proteome ... single or multidimensional chromatography or go straight ...
Biology Products: